Valsartan/amlodipine/chlorthalidone - Kyungdong Pharm
Alternative Names: KDF-1901Latest Information Update: 08 Oct 2025
At a glance
- Originator Kyungdong Pharm
- Class Antihypertensives; Branched-chain amino acids; Cardiovascular therapies; Small molecules; Sulfonamides; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Essential hypertension